Status:
UNKNOWN
Fibrin Sealant in Eyelid Surgery
Lead Sponsor:
University of Calgary
Conditions:
Blepharoptosis
Ecchymosis; Eyelid
Eligibility:
All Genders
19+ years
Phase:
PHASE2
PHASE3
Brief Summary
This study is looking at the effect of Tisseel in eyelid surgery. Fibrin sealants (Tisseel) cause there to be less bleeding during surgery. Surgeons have used Tisseel for over two decades to reduce br...
Detailed Description
The study is designed as a superiority randomized control trial. Tisseel will be used for hemostasis during the closure of one blepharoplasty incision. The side to receive Tisseel will be determined u...
Eligibility Criteria
Inclusion
- • Patient undergoing bilateral upper eyelid blepharoplasty
Exclusion
- Hypersensitivity to the fibrin adhesive or components of it
- Religious belief prohibiting the use of blood products
- Pregnancy
- Immunodeficiency
- Age ≤18 years of age
- Breastfeeding women
Key Trial Info
Start Date :
May 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2023
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT05358977
Start Date
May 1 2022
End Date
June 1 2023
Last Update
May 3 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.